Dendri-TAC and their use as theranostics
US10286091B2 · kind B2 · utility
0Cited by
0References
25Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 19, 2016 |
| Grant date | May 14, 2019 |
| Priority date | — |
| Expiry date | May 19, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC08G83/008
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel amphiphilic dendrimers, hereafter denoted Dendri-TAC. The present invention also relates to perfluorocarbon nanoemulsions stabilized by these amphiphilic dendrimers and their uses for in vivo diagnostic and/or for therapy, notably as theranostic tools, for detection and/or treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.